Infectious Disease Clinics of North America

Papers
(The TQCC of Infectious Disease Clinics of North America is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Candidemia and Invasive Candidiasis136
Aspergillosis116
Multidrug-Resistant Bacteria in the Community98
Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations80
Resistance in Vancomycin-Resistant Enterococci76
Cryptococcosis67
Mucormycosis67
Histoplasmosis63
Coccidioidomycosis50
Nosocomial Fungal Infections48
Staphylococcal Skin and Soft Tissue Infections45
Resistance to Antifungal Drugs44
Necrotizing Soft Tissue Infections44
Recent Trends in the Epidemiology of Fungal Infections43
Aminoglycoside Resistance41
Epidemiology of Lyme Disease37
Health Care–Acquired Infections in Low- and Middle-Income Countries and the Role of Infection Prevention and Control37
Blastomycosis34
Skin and Soft Tissue Infections in Patients with Diabetes Mellitus33
COVID-19 Pathogenesis and Clinical Manifestations33
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection31
Disinfection and Sterilization in Health Care Facilities30
Vancomycin-Resistant Enterococci29
Decolonization of Staphylococcus aureus29
Emerging Issues in Antifungal Resistance29
COVID-19 and Pregnancy27
Multidrug-Resistant Gram-Negative Bacteria26
Skin and Soft Tissue Infections in Persons Who Inject Drugs25
Agents of Last Resort25
Human Babesiosis23
Tuberculosis in Children23
Emerging Fungal Infections23
Overview22
Prevention of Central-Line Associated Bloodstream Infections21
Syphilis20
Surgical Site Infections20
Lyme Arthritis20
Antifungals in Clinical Use and the Pipeline20
Cellulitis18
Ventilator-Associated Events17
COVID-19 Vaccines17
Infection Prevention during the Coronavirus Disease 2019 Pandemic16
Gram-Negative Skin and Soft Tissue Infections16
Urinary Tract Infections16
Awakening16
Bacteremia due to Methicillin-Resistant Staphylococcus aureus16
Update on the Epidemiology, Screening, and Management of Chlamydia trachomatis Infection16
The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections15
Antifungal Susceptibility Testing and Identification14
Powassan Virus Encephalitis14
Approach to the Patient with a Skin and Soft Tissue Infection13
Epidemiology and Clinical Presentation of COVID-19 in Older Adults13
Hand Hygiene, an Update12
Drug-Resistant Tuberculosis12
Update in Epidemiology and Management of Mycoplasma genitalium Infections12
COVID-19 in Children12
Human Granulocytic Anaplasmosis11
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant11
Water Safety and Health Care11
Strategies for Effective Infection Prevention Programs10
Cardiac Manifestations of Lyme Disease10
Pandemic Preparedness10
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children10
Health Care Environmental Hygiene10
Persistent Symptoms After Treatment of Lyme Disease10
Management and Prevention of Staphylococcus aureus Infections in Children10
Immunology of Fungal Infections9
Uses of Procalcitonin as a Biomarker in Critical Care Medicine9
Infectious Complications of Bite Injuries9
SARS-CoV-2 Virology9
Sexually Transmitted Human Papillomavirus9
Genital Herpes Infection9
The Evolving Role of the Clinical Microbiology Laboratory in Identifying Resistance in Gram-Negative Bacteria9
0.034209966659546